Shots: The US FDA has approved Xeljanz XR extended-release (11 & 22mg, qd) for the treatment of mod. to sev. active UC, after an inadequate response or intolerance to TNF […]readmore
Tags : Xeljanz XR
Shots: The P-IIIB/IV study results involve assessing of Xeljanz XR (11 mg, qd) as monothx. followed by MTX withdrawal vs Xeljanz XR + MTX in 530 patients in ratio (1:1) […]readmore